Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and iclaprim

levofloxacin has been researched along with iclaprim in 2 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(iclaprim)		Trials
(iclaprim)		Recent Studies (post-2010) (iclaprim)
4,3465812,20945716

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)iclaprim (IC50)
Dihydrofolate reductaseHomo sapiens (human)0.486
Dihydrofolate reductaseStaphylococcus aureus0.3076
Dihydrofolate reductaseEscherichia coli K-120.4858
Dihydrofolate reductasePneumocystis carinii0.9644
Dihydrofolate reductaseStreptococcus pneumoniae TIGR40.6055

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fritsche, TR; Jones, RN; Sader, HS1
Hammerschlag, MR; Hawser, S; Islam, K; Kohlhoff, SA; Reznik, T; Roblin, PM1

Other Studies

2 other study(ies) available for levofloxacin and iclaprim

ArticleYear
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States

2009
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5

    Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Folic Acid Antagonists; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pyrimidines

2004